SCHEMBL30725813

SCHEMBL30725813

C=CC(=O)N1C[C@@H]2C(=O)N(C)c3c(c4cc(F)c(-c5c(O)cccc5F)nc4n(-c4c(C(C)C)ncnc4C(C)C)c3=O)N2C[C@H]1C

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KRAS P01116 20/20 0.65
SOS1 Q07889 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24692219 0.97 KRAS (0.65) KRASSOS1
SCHEMBL24692619 0.93 KRAS (0.73) KRASSOS1
SCHEMBL30725810 0.92 KRAS (0.60) KRAS
SCHEMBL27147257 0.92 KRAS (0.66) KRASSOS1
SCHEMBL30725818 0.91 KRAS (0.58) KRASSOS1
SCHEMBL27140620 0.91 KRAS (0.58) KRASSOS1
SCHEMBL27140929 0.91 KRAS (0.65) KRASSOS1
SCHEMBL24692947 0.90 KRAS (0.59) KRASSOS1
SCHEMBL24692380 0.89 KRAS (0.62) KRASSOS1
SCHEMBL25829344 0.89 KRAS (0.62) KRASSOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4053118-B1 SUBSTITUTED HETEROCYCLIC FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF GENFLEET THERAPEUTICS SHANGHAI INC (CN) 2024-10-09 EP disclosed
EP-4328229-A2 SUBSTITUTED HETEROCYCLIC FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Genfleet Therapeutics (Shanghai) Inc. (CN) 2024-02-28 EP disclosed